文献速递临床试验与 GCP

不同剂量右美托咪定对全麻下老年髋关节置换术患者围术期血流动力学及术后恢复质量的影响:一项随机对照试验

Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: a randomized controlled trial.
PubMed 文献 · Trials · 2023-06-08

该前瞻性随机双盲对照试验将老年髋关节置换术患者随机分入生理盐水(NS)与咪达唑仑(MD)对照组(n=30)及不同剂量右美托咪定组(D0.25/D0.5/D0.75,n=30),评估不同负荷剂量右美托咪定对围术期血流动力学及全麻后恢复的影响。结果显示D0.5和D0.75组在多个时间点MAP和HR显著降低(P<0.05),MAP和HR下降超过基线20%的患者比例更高;D0.25组血流动力学变化与对照组差异不大(P>0.05)。右美托咪定较NS显著减轻苏醒期躁动或谵妄(P<0.05),D0.5和D0.75组评分低于D0.25组(P<0.05),各组苏醒和拔管时间无差异(P>0.05)。作者结论认为0.25-0.5 μg/kg负荷后0.5 μg/kg/h持续输注可能提供舒适恢复伴轻微血流动力学抑制,但需警惕高剂量对血流动力学的抑制。

要点

  • D0.5和D0.75组在切皮、术毕及拔管后多个时间点MAP和HR显著降低(P<0.05)。
  • D0.25组围术期MAP和HR变化与MD及NS组差异不大(P>0.05)。
  • 右美托咪定较NS显著减轻苏醒期躁动或谵妄(P<0.05),各组苏醒和拔管时间无差异(P>0.05)。

核心结论

  • 右美托咪定可减轻全麻复合七氟烷吸入老年髋关节置换术患者的躁动而不延迟苏醒。
  • 高剂量右美托咪定围术期需警惕血流动力学抑制。
  • 0.25-0.5 μg/kg初始负荷后0.5 μg/kg/h持续输注可能提供舒适恢复伴轻微血流动力学抑制。

研究设计与样本

  • 前瞻性随机双盲对照临床试验。
  • 患者随机分入生理盐水(NS)与咪达唑仑(MD)对照组(n=30)及不同剂量右美托咪定组(D0.25/D0.5/D0.75,n=30)。
  • D0.25/D0.5/D0.75组分别以0.25/0.5/0.75 μg/kg初始负荷15 min,随后0.5 μg/kg/h持续输注至术毕。
  • MD组麻醉诱导开始时给予0.03 mg/kg咪达唑仑。
  • 试验注册号ClinicalTrial.gov NCT05567523,注册日期2022年10月5日。

主要发现

  • 与MD和NS组相比,D0.5和D0.75组在切皮、术毕及拔管至拔管后30 min等多个时间点MAP显著降低(P<0.05)。
  • 与MD和NS组相比,D0.5和D0.75组在麻醉诱导、术毕及拔管至术后2 h等时间点HR显著降低(P<0.05)。
  • D0.25组整个围术期MAP和HR变化与MD及NS组差异不大(P>0.05)。
  • MAP和HR下降超过基线20%的患者比例在D0.75和D0.5组高于其他所有组。
  • 与NS组相比,D0.5和D0.75组术始到术毕MAP低于基线20%以上的RR的95%CI大于1;D0.75组RR的95%CI直至患者全麻苏醒仍大于1(P<0.05);D0.5组在诱导和拔管时HR低于基线20%以上的RR的95%CI大于1(P<0.05)。

临床怎么用

  • 作者认为右美托咪定可减轻全麻复合七氟烷吸入老年髋关节置换术患者的躁动而不延迟苏醒。
  • 作者建议警惕高剂量右美托咪定整个围术期的血流动力学抑制。
  • 作者认为0.25-0.5 μg/kg初始负荷后0.5 μg/kg/h持续输注可能提供舒适恢复伴轻微血流动力学抑制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dexmedetomidine could provide some advantages to prevent postoperative complications in elderly patients undergoing under general anaesthesia. However, dexmedetomidine inhibits haemodynamics to some extent due to its sympathetic inhibition. OBJECTIVE: To evaluate the effects of different doses of dexmedetomidine on haemodynamics during surgery and recovery after general anaesthesia in elderly patients undergoing hip replacement. METHODS: This was a prospective randomized double-blind controlled clinical trial. Eligible patients were randomly allocated into comparative groups (normal saline (NS) and midazolam (MD), n = 30) and dexmedetomidine groups at different doses (D0.25/D0.5/D0.75, n = 30). In the D0.25/D0.5/D0.75 groups, dexmedetomidine was administered at different initial loading doses (0.25/0.5/0.75 μg/kg for 15 min) following 0.5 μg/kg/h continuous infusion until the end of the operation. In the MD group, patients were administered 0.03 mg/kg midazolam at the beginning of anaesthesia induction. RESULTS: Compared to the MD and NS groups, there were significant decreases in MAP in the D0.5 and D0.75 groups at many time points, such as skin incision, end of operation, and from extubation until 30 min after extubation (P < 0.05); there were also significant decreases in HR in the D0.5 and D0.75 groups at time points including anaesthesia induction, end of operation, and from extubation to 2 h after operation (P < 0.05). In the D0.25 group, there were few differences in the changes in MAP and HR compared to the MD and NS groups during the entire perioperative period (P > 0.05). Moreover, the percentage of patients whose MAP and HR decreased > 20% of baseline was higher in the D0.75 and D0.5 groups than that in all other groups. Compared to the NS group, from the beginning to the end of the operation, the 95% confidence interval (CI) of RR for MAP below > 20% of baseline in the D0.5 and D0.75 groups was greater than 1. In particular, the CI of the RR in the D0.75 group was greater than 1 until the patient awoke from general anaesthesia (P < 0.05). In addition, the CI of the RR for HR below > 20% of baseline in the D0.5 group was greater than 1 compared to the NS group at the time of induction and extubation (P < 0.05). There was no significant difference in the possibility of developing hypotension or bradycardia in the MD or D0.25 groups compared to the NS group (P > 0.05). The recovery quality of patients during the post-anaesthesia period was also observed. No differences were observed among all the groups in the time to awakening or extubation after general anaesthesia (P > 0.05). According to the Riker Sedation-agitated Scale, dexmedetomidine significantly alleviated emergency agitation or delirium compared to NS (P < 0.05). In addition, the scores in the D0.5 and D0.75 groups were lower than those in the D0.25 group (P < 0.05). CONCLUSION: Dexmedetomidine could alleviate the agitation of elderly patients undergoing hip replacement after intravenous general anaesthesia combined with inhaled sevoflurane without delayed recovery. However, it is necessary to be vigilant about the haemodynamic inhibition of the drug at high dosages throughout the perioperative period. Dexmedetomidine 0.25-0.5 μg/kg as the initial loading dose followed by 0.5 μg/kg/h continuous infusion might provide comfortable recovery after general anaesthesia with slight haemodynamic inhibition. TRAIL REGISTRATION: ClinicalTrial.gov, No. NCT05567523. Registered 05 October 2022, https://clinicaltrials.gov/ct2/show/NCT05567523?term=NCT05567523&draw=2&rank=1 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liu H, Gao M, Zheng Y, et al. Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: a randomized controlled trial. Trials. 2023. PMID: 37291651. doi:10.1186/s13063-023-07384-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。